GlassScriptPhysician profile
Harry Moulis
NPI 1508866526
$1,491.19
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,429 · 2020: $62.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $317.00 | 2019-2020 | |
| Abbvie INC. | $227.95 | 2019 | |
| Pfizer INC. | $184.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.31 | 2019 | |
| Gilead Sciences, INC. | $113.86 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $97.25 | 2019 | |
| Qol Medical, LLC | $79.23 | 2019 | |
| Ironwood Pharmaceuticals, INC | $74.72 | 2019 | |
| Janssen Biotech, INC. | $65.88 | 2019 | |
| Concordia Pharmaceuticals INC. | $47.91 | 2019 | |
| Allergan, INC. | $30.92 | 2019 | |
| Ethicon US, LLC | $29.20 | 2020 | |
| Shionogi INC | $23.50 | 2019 | |
| Intercept Pharmaceuticals, INC. | $20.63 | 2019 | |
| Romark Laboratories, Lc | $17.21 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $15.61 | 2019 | |
| Shire North American Group INC | $14.31 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Moulis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.